PAN2 and bladder transitional cell carcinoma: Moreover, the combination of USP52 depletion and IKE synergistically inhibited the progression of BLCA by inducing ferroptosis, suggesting a potential novel therapeutic strategy for treating BLCA (Figure 8J).